ELIV5
ELIV5 Therapeutics aims to develop a new class of antifungal drugs that target a critical step in fungal metabolism required for pathogen survival and virulence. ELIV5 Team: Choukri Ben Mamoun
Read MoreBow Therapeutics
Bow Therapeutics is developing isolation of human monoclonal antibodies against Chikungunya Virus Glycoprotein using Single B-cell sorting Technology. Bow Therapeutics Team: George Georgiev Jose Quiroz
Read MoreUnicrobe
We will provide bacterial genome editing services using CRISPR-Cas technologies for academic and industrial customers interested in improving human health and developing bacterial technologies. Team: Wenyan Jiang – CEO, CSO Yuchen Qi – Business Development
Read MoreMouSensor, Inc.
MouSensors provide the first genetic platform for smell pharmacology to assist humans in scent detection tasks such as non-invasive cancer diagnosis, Tuberculosis identification, explosives detection etc. Team: Paul Feinstein, PhD. – Co-founder Charlotte D’Hulst, PhD. – Co-founder
Read MoreIonica Sciences
Ionica Sciences is developing a spectroscopy-based diagnostic platform capable of targeting myriad infectious diseases, with Lyme disease serving as our initial focus and test case. Team: Omar Green – CEO, Founder Joel Tabb – President, Co-Founder
Read MoreProof Bio Strips
Disposable paper test sensors for fast detection of bacterial food spoilage. Proof Bio Strips Team: Chang Kang
Read MoreLucida Pathology
A decision support system for automated analysis and diagnosis of histopathology biopsies comprising a physical scanning platform, algorithms, and software. Lucida Pathology Team: Amire Handzel
Read MoreGentroma
A portable DNA sequencer that can make finding out information about one’s genetic ancestry, disease risk, and other factors available to the masses, cost-effectively. Team: Krista Fretes, CEO Parth Shah, CTO
Read MoreAvalia Immunotherapies
Avalia Immunotherapies – A synthetic immunotherapy platform for self-adjuvanting vaccines, with a unique mode of action, aiming to improve clinical outcomes for cancer, allergy and infectious disease. Avalia Immunotherapies Team: Shivali Gulab, CEO
Read MoreInnovative Neurons LLC
Innovative Neurons LLC, makers of the Fast Access Safety Technology Syringe. (F.A.S.T) Innovative Neurons LLC Team: Aleef Mahmud
Read More